CRI’s Director, Professor Michael Nilsson, has been awarded over $400,000 for an NHMRC Ideas grant exploring the impact of commonly described medications on the trajectory of recovery in stroke survivors.
The three (3) year project, in partnership with researchers at the University of Gothenburg (Sweden), will use the Swedish patient registries (the most comprehensive and best characterised sources of patient data in the world) to determine why some patients experience cognitive decline after stroke.
